Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Issue: Health products
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 61 - 75 of 135 items.
Authorization of Janssen COVID-19 Vaccine with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2021-03-08
Authorization of AstraZeneca COVID-19 Vaccine with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2021-03-01
COVID-19 Vaccine Moderna: Updated English-only Global Vial and Carton Labels and Post-Market Adverse Reaction Information
AlertHealth professional risk communication | 2021-02-22
Pfizer-BioNTech COVID-19 Vaccine: Updated Dosage and Administration and Post-Market Adverse Reaction Information
AlertHealth professional risk communication | 2021-02-09
GILENYA (fingolimod) - Risk of Liver Injury
AlertHealth professional risk communication | 2021-01-18
Important Safety Information on SUBOXONE (buprenorphine and naloxone) and the Risk of Overdose or Underdose when Switching Between Dosage Forms or Routes of Administration
AlertHealth professional risk communication | 2021-01-07
Importation of German-labelled Hydromorphon Ethypharm Kalceks (Hydromorphone Hydrochloride Solution for Injection) due to Potential Shortage of Canadian-labelled HYDROmorphone
AlertHealth professional risk communication | 2021-01-06
Authorization of Moderna COVID-19 Vaccine with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2020-12-23
Bacitracin for Injection (50,000 IU per vial) and the Risk of Nephrotoxicity and Anaphylactic Reactions
AlertHealth professional risk communication | 2020-12-21
Authorization of Bamlanivimab with English-only Labels for Use in Relation to the COVID-19 Pandemic
AlertHealth professional risk communication | 2020-12-18
ELMIRON (pentosan polysulfate sodium) and the Risk of Pigmentary Maculopathy
AlertHealth professional risk communication | 2020-12-15
Pfizer-BioNTech COVID-19 vaccine: Health Canada recommendations for people with serious allergies
AlertPublic advisory | 2020-12-12
Authorization of Pfizer-BioNTech COVID-19 Vaccine with English-only Carton and Vial Labels
AlertHealth professional risk communication | 2020-12-12
Importation of US-labelled Dexrazoxane for Injection distributed by Mylan Pharmaceuticals ULC due to shortage of Canadian-labelled Dexrazoxane
AlertHealth professional risk communication | 2020-12-01
PICATO (ingenol mebutate gel, 0.015% and 0.05%) - Product Withdrawal in Canada due to Potential Increased Risk of Skin Cancer
AlertHealth professional risk communication | 2020-10-27